Analyst upgrades: TEVA, NVAX, COCO, FIC and TEN
Posted Oct 31st 2007 10:15AM by Eric Buscemi
Filed under: Analyst reports, Analyst upgrades and downgrades, Teva Pharm Indus ADR (TEVA)
MOST NOTEWORTHY: Teva Pharma, Novavax, Corinthian Colleges, Fair Isaac and Tenneco were today's noteworthy upgrades:
- Friedman Billings upgraded Teva Pharmaceutical (NASDAQ: TEVA) to Outperform from Market Perform following Teva's better-than-expected Q3 report and guidance.
- Oppenheimer upgraded shares of Novavax (NASDAQ: NVAX) to Buy from Neutral based on positive expectations for Ph I/IIa pandemic influenza data, the start of clinical trials for seasonal influenza, and expected announcement of a vaccine product candidate in Q4.
- Corinthian Colleges (NASDAQ: COCO) was upgraded to Buy from Neutral at Merrill following its better-than-expected Q1 report and guidance.
- Citigroup upgraded of Fair Isaac (NYSE: FIC) to Buy from Hold shares to reflect the company's strong Q4 results and improved outlook.
- Tenneco (NYSE: TEN) was raised to Outperform from Market Perform at Wachovia based on valuation and revenue opportunities in commercial truck market.
OTHER UPGRADES:
Tags: analyst, coco, corinthian, energizer, enr, fair isaac, FairIsaac, fic, lecg, metropcs, novavax, nvax, pcs, post properties, PostProperties, pps, ten, tenneco, teva, upgrade, xprt